Prospects and Challenges of Applying RNAi Combined with High Content Screening in Drug Development

YANG Ya-ping,LI Min
DOI: https://doi.org/10.3321/j.issn:1003-3734.2009.08.004
2009-01-01
Abstract:Combination of RNAi with high content screening(HCS) provides a powerful tool to carry out large-scale screens to discover and validate drug targets.It is also very useful in compound screening and mechanism research.Parallel use of chemical genetic approach and genome-wide RNAi screening on HCS platform can facilitate identifying drug targets and discovering leading compounds at the same time.The application of RNAi combined with HCS shows significant advantages in drug development.However,it is still often limited by technical challenges in the processes of acquisition,management and analysis of data,particularly in automatic analysis for massive images,such as cellular segmentation and cellular phenotype classification.
What problem does this paper attempt to address?